Determination of leukemogenic benzene exposure concentrations : refined analyses of the pliofilm cohort

<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
  <record>
    <leader>00000nab a2200000 i 4500</leader>
    <controlfield tag="001">MAP20071027838</controlfield>
    <controlfield tag="003">MAP</controlfield>
    <controlfield tag="005">20080418121653.0</controlfield>
    <controlfield tag="007">hzruuu---uuuu</controlfield>
    <controlfield tag="008">970625s1996    usa||||    | |00010|eng d</controlfield>
    <datafield tag="040" ind1=" " ind2=" ">
      <subfield code="a">MAP</subfield>
      <subfield code="b">spa</subfield>
    </datafield>
    <datafield tag="084" ind1=" " ind2=" ">
      <subfield code="a">872</subfield>
    </datafield>
    <datafield tag="100" ind1="1" ind2=" ">
      <subfield code="0">MAPA20080274511</subfield>
      <subfield code="a">Schnatter, A. Robert</subfield>
    </datafield>
    <datafield tag="245" ind1="1" ind2="0">
      <subfield code="a">Determination of leukemogenic benzene exposure concentrations</subfield>
      <subfield code="b">: refined analyses of the pliofilm cohort</subfield>
      <subfield code="c">A. Robert Schnatter, Mark J. Nicolich, and Michael G. Bird</subfield>
    </datafield>
    <datafield tag="520" ind1=" " ind2=" ">
      <subfield code="a">The above research suggests that benzene dose rate effects may be important, which the authors define as an effect which relies on exposure concentration in a manner other than as a simple, linear product term of cumulative exposure</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080585679</subfield>
      <subfield code="a">Higiene industrial</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080588953</subfield>
      <subfield code="a">Análisis de riesgos</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080543112</subfield>
      <subfield code="a">Benceno</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080619480</subfield>
      <subfield code="a">Enfermedades profesionales</subfield>
    </datafield>
    <datafield tag="650" ind1="1" ind2="1">
      <subfield code="0">MAPA20080547943</subfield>
      <subfield code="a">Leucemia</subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20080201999</subfield>
      <subfield code="a">Nicolich, Mark J.</subfield>
    </datafield>
    <datafield tag="700" ind1="1" ind2=" ">
      <subfield code="0">MAPA20080155650</subfield>
      <subfield code="a">Bird, Michael G.</subfield>
    </datafield>
    <datafield tag="740" ind1="0" ind2=" ">
      <subfield code="a">Risk analysis</subfield>
    </datafield>
    <datafield tag="773" ind1="0" ind2=" ">
      <subfield code="t">Risk analysis</subfield>
      <subfield code="d">New York and London</subfield>
      <subfield code="g">Vol. 16, nº 6, 1996 ; p. 833-840</subfield>
    </datafield>
  </record>
</collection>